Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Januvia Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel low-cost route for Sitagliptin intermediates via chiral resolution. Reduces catalyst costs and simplifies scale-up for API manufacturing.